Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients

Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients

Abstract. Background:. Due to the different treatments for low-volume metastatic prostate cancer (PCa) as well as high-volume ones, evaluation of bone metastatic status is clinically significant. In this study, we evaluated the correlation between pre-treatment plasma fibrinogen and the burden of bo...

Full description

Bibliographic Details
Main Authors:	Gan-Sheng Xie, Gang Li, Yu Li, Jin-Xian Pu, Yu-Hua Huang, Jin-Hu Li, Hu-Ming Yin, Peng Lyu
Format:	Article
Language:	English
Published:	Wolters Kluwer 2019-11-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000000506

Similar Items

Impact of high-volume disease in Asian population with newly diagnosed metastatic prostate cancer
by: Yung-Ting Cheng, et al.
Published: (2018-01-01)

A novel prognostic model for Japanese patients with newly diagnosed bone‐metastatic hormone‐naïve prostate cancer
by: Yasuhide Miyoshi, et al.
Published: (2021-03-01)

microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer
by: Ahmed Hussein Zedan, et al.
Published: (2018-05-01)

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
by: Daniel C. Parker, et al.
Published: (2020-02-01)

Bone Metastases Pattern in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Real-World Analysis in the SEER Database
by: Xiaojing Yang, et al.
Published: (2020-01-01)

When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study
by: Yiwei Lin, et al.
Published: (2017-06-01)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
by: Bertram E. Yuh, et al.
Published: (2019-09-01)

Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer
by: Jibril Oyekunle Bello
Published: (2017-05-01)

Bone scintigraphy in staging of newly diagnosed prostate cancer in regard of different risk groups
by: Sabina Sevcenco, et al.
Published: (2019-06-01)

Can PSA Predict Bone Metastasis amongst Newly Diagnosed Prostate Cancer Patients?
by: D. Ojuka, MBChB, MMed, Surgery, et al.
Published: (2018-01-01)

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
by: Jianai Sun, et al.
Published: (2020-11-01)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
by: Nicolaas Lumen, et al.
Published: (2021-07-01)

Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening
by: Ridwan Alam, et al.
Published: (2017-02-01)

Metastatic screening for patients with newly diagnosed breast cancer: Who and how?
by: Jenny Edge, et al.
Published: (2020-04-01)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
by: Watanabe K, et al.
Published: (2021-08-01)

Bone disease in newly diagnosed lupus nephritis patients.
by: Aline Lázara Resende, et al.
Published: (2014-01-01)

A narrowing range of bone scan in newly diagnosed prostate cancer patients: A retrospective comparative study
by: Berat Cem Özgür, et al.
Published: (2015-01-01)

The Utilization of Gleason Grade as the Primary Criterion for Ordering Nuclear Bone Scan in Newly Diagnosed Prostate Cancer Patients
by: Chad W. M. Ritenour, et al.
Published: (2009-01-01)

Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer
by: Wen‐Cai Liu, et al.
Published: (2021-04-01)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
by: Chang-Yuan Liu, et al.
Published: (2019-08-01)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
by: Qianwen Cheng, et al.
Published: (2021-03-01)

Devising and external validation of a prognostic classification of metastatic involvement risk to pelvic lymph nodes in patients with newly diagnosed prostate cancer
by: E. A. Leusik, et al.
Published: (2015-12-01)

Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
by: David Thurtle, et al.
Published: (2019-06-01)

Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? a retrospective study
by: Mohammed A. Al-Ghazo, et al.
Published: (2010-12-01)

Empowerment of men newly diagnosed with prostate cancer in treatment decision making
by: Davison, B. Joyce
Published: (2013)

Empowerment of men newly diagnosed with prostate cancer in treatment decision making
by: Davison, B. Joyce
Published: (2013)

Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
by: Hualin Song, et al.
Published: (2020-03-01)

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
by: David M. Kern, et al.
Published: (2020-08-01)

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy
by: Shintaro Narita, et al.
Published: (2019-11-01)

Evaluation of bone mineral status in prepuberal children with newly diagnosed type 1 diabetes
by: Jung Gi Roh, et al.
Published: (2018-09-01)

The Prognostic Value of Combination of Plasma Fibrinogen and CA19-9 in Non-Distant Metastatic Breast Cancer Patients Undergoing Surgery
by: Hu W, et al.
Published: (2020-09-01)

External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer
by: Yun-Jie Yang, et al.
Published: (2018-01-01)

PSMA-PET/CT-Positive Paget Disease in a Patient with Newly Diagnosed Prostate Cancer: Imaging and Bone Biopsy Findings
by: Michael Froehner, et al.
Published: (2017-01-01)

Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer
by: Su Y, et al.
Published: (2021-05-01)

Utility of circulating tumor DNA methylation biomarkers in newly diagnosed prostate cancer
by: M.T. Bjerre, et al.
Published: (2020-07-01)

Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer
by: Elan Gorshein, et al.
Published: (2017-01-01)

Coping, information preferences, and treatment choice in men newly diagnosed with prostate cancer
by: Levin, Anna Yudit
Published: (2011)

Coping, information preferences, and treatment choice in men newly diagnosed with prostate cancer
by: Levin, Anna Yudit
Published: (2011)

Coping, information preferences, and treatment choice in men newly diagnosed with prostate cancer
by: Levin, Anna Yudit
Published: (2011)

Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy
by: Gan-Sheng Xie, et al.
Published: (2016-01-01)